RECRUITING

Health Education Approach to Lung Screening

Talk to us

Conditions

Lung CancerScreening

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Evaluate the impact of the patient navigation program on the proportion of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT)

Official Title

Health Education Approach to Lung Screening (HEALS)

Quick Facts

Study Start:2023-10-10
Study Completion:2026-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06070870

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Meets current USPSTF guidelines for lung cancer screening (LCS)
  2. * 20 pack-year smoking history Note: A pack-year is a way of calculating how much a person has smoked in their lifetime.
  3. * Currently smokes or has quit smoking within the past 15 years
  4. * Identifies as Black or African-American Note: Both Hispanic/Latino and Non-Hispanic/Latino patients are eligible as long as they also identify as Black or African-American (eg, Afro-Latino).
  5. * Willing to complete all navigation-related study activities
  6. * Able to understand and the willingness to sign a written informed consent document
  1. * Known history of cancer (except squamous cell skin cancer), or coughing up blood in the past 5 years, as reported by the individual
  2. * Has undergone a previous lung cancer screening
  3. * Inability to speak English
  4. * Medical, psychological, or social condition that, in the opinion of the investigator, may increase the patient's risk or limit the patient's adherence with study requirements

Contacts and Locations

Study Contact

Kendra Rowe
CONTACT
804-628-6430
MasseyCPC@vcu.edu
Massey CPC Team
CONTACT
MasseyCPC@vcu.edu

Principal Investigator

Vanessa Sheppard, PhD
PRINCIPAL_INVESTIGATOR
Virginia Commonwealth University

Study Locations (Sites)

University of North Carolina-Chapel Hill
Carrboro, North Carolina, 27510
United States
Medical University of South Carolina
Charleston, South Carolina, 29425
United States
Virginia Commonwealth University
Richmond, Virginia, 23298
United States

Collaborators and Investigators

Sponsor: Virginia Commonwealth University

  • Vanessa Sheppard, PhD, PRINCIPAL_INVESTIGATOR, Virginia Commonwealth University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-10
Study Completion Date2026-04-30

Study Record Updates

Study Start Date2023-10-10
Study Completion Date2026-04-30

Terms related to this study

Keywords Provided by Researchers

  • Lung cancer
  • Screening

Additional Relevant MeSH Terms

  • Lung Cancer